Madrigal Pharmaceuticals

Trademark usage description

pharmaceutical preparations for the treatment of patients with non-alcoholic steatohepatitis (nash) with liver fibrosis. licensing services, namely, Read More

Vienna Information

26 . 11 . 3

More than two lines or two bandsPlus de deux lignes ou de deux bandes

26 . 11 . 9

Oblique lines or bandsLignes ou bandes obliques

26 . 11 . 12

Curved lines or bands (except a 26.11.13)Lignes ou bandes courbes (excepté a 26.11.13)

26 . 1 . 1

CirclesCercles

26 . 1 . 3

One circle or ellipseUn cercle ou une ellipse

26 . 1 . 12

Circles or ellipses containing one or more other geometrical figures -- Note: Including circles or ellipses containing bent or straight lines (except 26.1.10).Cercles ou ellipses contenant une ou plusieurs autres figures géométriques -- Note: Y compris les cercles ou ellipses contenant des lignes courbées ou droites (excepté 26.1.10).

26 . 1 . 24

Circles or ellipses with dark surfaces or parts of surfacesCercles ou ellipses avec surface ou partie de la surface foncée

25 . 7 . 20

Surfaces or backgrounds covered with lines or bandsSurfaces ou fonds couverts de lignes ou de bandes

Classification Information

Class [005]
Pharmaceutical preparations for the treatment of patients with non-alcoholic steatohepatitis (NASH) with liver fibrosis.

Classification kind code

Class [045]
Licensing services, namely, licensing of pharmaceutical intellectual property rights to third parties.

Classification kind code

Mark Details

Serial Number

2302127

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 42 on 16^th Apr 2025	Advertised
Submitted for opposition 27 on 19^th Mar 2025	Approval Notice Sent
Submitted for opposition 26 on 19^th Mar 2025	Approved
Submitted for opposition 22 on 11^th Mar 2025	Search Recorded
Submitted for opposition 256 on 28^th Oct 2024	Notification of Possible Opposition Sent
Submitted for opposition 257 on 28^th Dec 2023	Designation Notification - Madrid Protocol
Submitted for opposition 31 on 27^th Dec 2023	Formalized
Submitted for opposition 1 on 27^th Dec 2023	Created
Submitted for opposition 228 on 30^th Oct 2023	International Registration
Submitted for opposition 30 on 30^th Oct 2023	Filed

Madrigal Pharmaceuticals

Classification Information

Class [005]Pharmaceutical preparations for the treatment of patients with non-alcoholic steatohepatitis (NASH) with liver fibrosis.

Classification kind code

Class [045]Licensing services, namely, licensing of pharmaceutical intellectual property rights to third parties.

Classification kind code

Mark Details

Serial Number

Mark Type

Legal History

Class [005]
Pharmaceutical preparations for the treatment of patients with non-alcoholic steatohepatitis (NASH) with liver fibrosis.

Class [045]
Licensing services, namely, licensing of pharmaceutical intellectual property rights to third parties.